Please ensure Javascript is enabled for purposes of website accessibility A dose of immunity during a market downturn - Janus Henderson Investors

A dose of immunity during a market downturn

Accelerating innovation in the biotechnology sector may offer investors new potential growth opportunities. In a market environment where we believe investors should tread carefully, Jennifer Nichols, Client Portfolio Manager and Matthew Bullock, EMEA Head of Portfolio Construction and Strategy discussed how healthcare’s unique blend of defensive characteristics and growth potential may offer immunity from the downturn.

Jennifer Nichols, CFA

Jennifer Nichols, CFA

Client Portfolio Manager


Matthew Bullock

Matthew Bullock

EMEA Head of Portfolio Construction and Strategy


8 Mar 2023
30 minute watch

JHI

JHI

Jennifer Nichols, CFA

Jennifer Nichols, CFA

Client Portfolio Manager


Matthew Bullock

Matthew Bullock

EMEA Head of Portfolio Construction and Strategy


8 Mar 2023
30 minute watch

Subscribe

Sign up for timely perspectives delivered to your inbox.

Submit